Partnership with DTx Pharma to optimize antisense oligonucleotides as a gene therapy for CMT1A

The CMT Research Foundation (CMTRF), a nonprofit focused solely on delivering treatments and cures for Charcot-Marie-Tooth, today announced it has partnered with DTx Pharma, an RNA medicines company [...]